ADAMTS9 and hepatocellular carcinoma: In particular, ADAMTS9-AS1 is highly expressed in hepatocellular carcinoma cells and it exacerbates cell proliferation, migration and invasion through the PI3K/AKT/mTOR pathways (Zhang et al., 2020).